Task Force Members
March 2011
Oren Cohen, Quintiles Transnational
Gregory Curt, AstraZeneca
Christine Dingivan, PPD
James Doroshow, National Cancer Institute
Ana Maria Garcia, sanofi-aventis
Richard Gaynor, Eli Lilly
Martine George, Pfizer
Allicia Girvan, Eli Lilly
William Hait, Johnson & Johnson
Roger Herdman, Institute of Medicine
Charles Hugh-Jones, sanofi-aventis
Svetlana Kobina, sanofi-aventis
Viren Mehta, Mehta Partners
Martin Murphy, CEO Roundtable on Cancer
Sharyl Nass, Institute of Medicine
Paolo Paoletti, GlaxoSmithKline
Phillip Porter, Hogan Lovells
Sheila Prindiville, National Cancer Institute
Wayne Rackoff, Johnson & Johnson
Mace Rothenberg, Pfizer
Debasish Roychowdhury, sanofi-aventis
August Salvado, Novartis
Josh Schafer, US Astellas
Ira Steinberg, sanofi-aventis
Dan Sullivan, H. Lee Moffitt Cancer Institute
John Wagner, Merck